Related Experiment Videos
The role of multimodality therapy in soft-tissue sarcoma
M F Brennan1, E S Casper, L B Harrison
1Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
Annals of Surgery
|September 1, 1991
Summary
This study on soft-tissue sarcomas found that brachytherapy radiation decreased local recurrence in extremity lesions but did not improve survival. Patient outcomes were similar whether or not they received adjuvant radiation.
Area of Science:
- Oncology
- Surgical Pathology
- Radiation Oncology
Background:
- Soft-tissue sarcomas are rare cancers affecting various body tissues.
- Extremities are the most frequent sites for these tumors.
- Liposarcoma and leiomyosarcoma are the predominant histopathologic subtypes.
Purpose of the Study:
- To describe the development of a prospective database for over 1600 soft-tissue sarcoma patients.
- To identify prognostic factors influencing recurrence and survival.
- To evaluate the efficacy of adjuvant brachytherapy radiation in extremity lesions.
Main Methods:
- Prospective data collection on 1600+ soft-tissue sarcoma patients over 8 years.
- Analysis of prognostic factors including site, histopathology, size, grade, and resection adequacy.
- A prospective randomized trial comparing adjuvant brachytherapy versus no adjuvant radiation for extremity lesions.
Main Results:
- Site, histopathology, size, grade, and resection adequacy are key prognostic factors.
- Adjuvant brachytherapy in extremity lesions reduced local recurrence but did not impact survival.
- Patients not randomized showed no difference in outcomes with or without adjuvant radiation.
Conclusions:
- Prognostic factors for soft-tissue sarcoma recurrence and survival are well-defined.
- Adjuvant brachytherapy may reduce local recurrence in extremity soft-tissue sarcomas.
- Current adjuvant radiation strategies do not significantly improve overall survival for these patients.